The Epione robotic-assisted platform supports interventional radiologists in treating inoperable or challenging early-staged tumors, due to their size, shape or location, without any surgical intervention.
This cutting-edge technology guides physicians to perform safe and effective percutaneous tumor ablation, a minimally invasive treatment in which one or multiple needles are inserted through the skin to destroy the tumor.
Percutaneous ablation is underutilized as a first-line treatment for cancer patients due to procedural workflow limitations and complexities. Epione is designed to overcome these challenges.®
The Epione robotic-assisted percutaneous ablation platform
Epione supports interventional radiologists with percutaneous ablation of abdominal and lung tumors* 1,2.
Compatible with a physician’s preferred ablation technology requiring single or multiple probes (MWA, RFA, cryo, IRE), Epione standardises minimally invasive ablation through image-guided navigation, advanced robotic assistance, and tumor ablation confirmation.
* Epione device is CE marked for abdomen and lung indications, and FDA cleared for abdominal ablation indication.
Epione® by the numbers
980+
Patients treatedworldwide
15+
Cancer centerinstallations
25+
Patents
Market approvals
FDA
Indications*
LiverPancreas KidneysLungsBones
* Epione device is CE marked for abdomen and lung indications, and FDA cleared for abdominalablation indication.CE mark for bone indication extension ongoing.
The technical difficulty involved in placing the needle (or needles) is reduced, and I can focus on patient safety and the oncological efficacy of tumour destruction.

Dr. Romain L'Huillier
Hospices Civils de Lyon (Lyon, France)
The needles are placed exactly where we predicted they would be. With the human hand, the needles are approximately where we predicted

Prof. Thierry de Baere
Gustave Roussy (Villejuif, France)

非常抱歉,您只有购买软件后才能查看完整软件教程!
| 版本号 | 软件大小 | 下载地址 |
|---|
| 版本号 | 软件大小 | 下载地址 |
|---|